Combination drug therapy for cryptosporidiosis in AIDS

Journal of Infectious Diseases

Volumn 178, Issue 3, 1998, Pages 900-903

  Smith, Nathaniel H ^c   Cron, Stanley ^c   Valdez, Luis M ^b   Chappell, Cynthia L ^c   Clinton White Jr , A ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; PAROMOMYCIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM PARVUM; DRUG EFFICACY; FEMALE; HUMAN; IMMUNOMODULATION; MALE; OOCYST; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0031708185     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/515352     Document Type: Article

References (15)

1. Flanigan T, Whalen C, Turner J, et al. Cryptosporidium infection and CD4 counts. Ann Intern Med 1992;116:840-2.
2. Benhamou Y, Bochet MV, Carriere J, et al. Effects of triple antiretroviral therapy including HIV protease inhibitors on chronic intestinal cryptosporidiosis and microsporidiosis in HIV-infected patients. Gastroenterology 1997;112:A930.
3. Hashmey R, Smith NH, Cron S, Graviss EA, Chappell CL, White AC Jr. Cryptosporidiosis in Houston, Texas: a report of 95 cases. Medicine 1997;76:118-39.
4. White AC Jr, Chappell CL, Hayat CS, Kimball KT, Flanigan TP, Good-game RW. Paromomycin for cryptosporidiosis in AIDS: a prospective, double-blind trial. J Infect Dis 1994;170:419-24.
5. Hewitt RG, Yiannoutsos CT, Carey J, et al. A double-blind, placebo-controlled trial of paromomycin for the treatment of cryptosporidiosis in patients with advanced HIV disease and CD4 counts under 150 (ACTG 192) [abstract 4]. In: 4th Conference on Retroviruses and Opportunistic Infections (Washington, DC). Alexandria, VA: Infectious Diseases Society of America 1997:65.
6. Blagburn BL, Soave R. Prophylaxis and chemotherapy: human and animal. In: Fayer R, ed. Cryptosporidium and cryptosporidiosis. New York, NY: CRC Press, 1997.
7. Soave R, Havlir D, Lancaster D, et al. Azithromycin therapy of AIDS-related cryptosporidial diarrhea: a multi-center, placebo-controlled, double-blind study [abstract 193]. In: Program and abstracts of the 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy (New Orleans). Washington, DC: American Society for Microbiology, 1993.
8. Blanshard C, Shanson DC, Gazzard BG. Pilot studies of azithromycin, letrazuril and paromomycin in the treatment of cryptosporidiosis. Int J STD AIDS 1997;8:124-9.
9. Vakil NB, Schwartz SM, Buggy DP, et al. Biliary cryptosporidiosis in HIV-infected people after the waterbome outbreak of cryptosporidiosis in Milwaukee. N Engl J Med 1996;334:19-23.
10. Genta RM, Chappell CL, White AC Jr, Kimball KT, Goodgame RW. Duodenal morphology and intensity of infection in AIDS-related cryptosporidiosis. Gastroenterology 1993;105:1769-75.
11. Goodgame RW, Genta RM, White AC Jr, Chappell CL. Intensity of infection in AIDS-associated cryptosporidiosis. J Infect Dis 1993;167:704-9.
12. Fries L, Hillman K, Crabb J, et al. Clinical and microbiologic effects of bovine anti-Cryptosporidium immunoglobulin (BACI) on cryptosporidial diarrhea in AIDS [abstract M2I]. In: Program and abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy (Orlando, FL). Washington, DC: American Society for Microbiology, 1994.
13. Keusch GT, Toncale FJ, Buchanan RD. Malabsorption due to paromomycin. Arch Intern Med 1970;125:273-6.
14. Dunne MW, Williams DJ, Young LS. Azithromycin and the treatment of opportunistic infections. Rev Contemp Pharmacother 1994;5:373.
15. Friedman CR, Soave R. Intravenous azithromycin for cryptosporidiosis in AIDS [abstract 190]. In: Program and abstracts of the Infectious Diseases Society of America 31st Annual Meeting (New Orleans). Alexandria, VA: Infectious Diseases Society of America, 1993:33-A.